NEW YORK (Reuters Health) – Regardless of dosage, frequency or route of administration, vitamin D3 (cholecalciferol) is more efficacious in raising serum 25 hydroxyvitamin D concentrations than vitamin…
NEW YORK (Reuters Health) – All-cause mortality rates among hypertensive patients treated with an angiotensin-converting enzyme inhibitor are 10% lower than in those whose treatment does not include…
NEW YORK (Reuters Health) – A program of patient education and planning aimed at treating exacerbations of chronic obstructive pulmonary disease early and reducing rates of hospitalization was…
NEW YORK (Reuters Health) – In patients with aspirin-related peptic ulcers, ulcer healing rates are comparable after esomeprazole therapy with or without aspirin continuation, Taiwanese researchers report in…
NEW YORK (Reuters Health) – Pooled data suggest that use of renin–angiotensin system (RAS) inhibitors, particularly angiotensin converting enzyme (ACE) inhibitors may increase the risk of angioedema, researchers…
NEW YORK (Reuters Health) – Pregnant women may safely receive mefloquine for malaria prophylaxis, researchers from Switzerland report in the April 10th online Clinical Infectious Diseases. “Women who…
NEW YORK (Reuters Health) – In patients with schizophrenia, chronic use of benzodiazepines is associated with an increased risk of death, whereas treatment with an antidepressant or several…
NEW YORK (Reuters Health) – Confirming recommendations, titrating beta-blocker dosage in ambulatory patients with heart failure up to an equivalent of 50 mg/d carvedilol reduces all-cause deaths and…
NEW YORK (Reuters Health) – Metformin appears to lower the risk of developing liver cancer in patients with type 2 diabetes, according to the results of a meta-analysis…
NEW YORK (Reuters Health) – Blood pressure lowering provides protection against intracranial bleeding in patients with cerebrovascular disease, including those on antithrombotic therapy, according to results of a…